High Tide Joins Cannabis Policy Council Amid Federal Rescheduling
Event summary
- High Tide Inc. and its subsidiary NuLeaf Naturals joined the National Compassionate Care Council (NCCC) as founding members on March 4, 2026.
- The NCCC aims to modernize healthcare standards and advance evidence-based policy for cannabinoid therapies.
- High Tide cited ongoing federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoids as a catalyst for the move.
- Founding members of the NCCC include several other prominent cannabinoid companies, such as Tilray and Medterra.
The big picture
High Tide's move to join the NCCC signals a proactive approach to navigating the evolving U.S. cannabis regulatory landscape, particularly as federal policy shifts toward greater acceptance and potential reimbursement for cannabinoid therapies. The council's formation reflects a growing recognition within the industry of the need for a unified voice in shaping policy and standardizing practices. This participation positions High Tide to potentially influence the direction of the market and secure advantages for its CBD-focused subsidiaries.
What we're watching
- Policy Influence
- The NCCC’s ability to shape federal and state medical cannabis policy will be a key indicator of High Tide’s long-term strategic success, particularly given the ongoing legislative shifts.
- Regulatory Headwinds
- How the NCCC navigates potential conflicts between state and federal regulations regarding cannabinoid therapies will determine the scope of its influence and impact on member companies.
- Competitive Landscape
- The degree to which the NCCC fosters collaboration versus competition among its members will influence the overall advancement of the cannabinoid sector and High Tide’s relative positioning.
Related topics